Showing 9 of 9 recruiting trials for “Tuberous Sclerosis”
Sapu003 in Advanced mTOR-sensitive Solid Tumors
TANDem-2: Closing the Gap to Interventions for TAND
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
👨⚕️ David M Ritter, MD, PhD, Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Jul 2023View details ↗
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
👨⚕️ Darcy A Krueger, MD, PhD, Children's Hospital Medical Center, Cincinnati📍 11 sites📅 Started Oct 2021View details ↗
Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis
👨⚕️ Andrea Pasini, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Jul 2021View details ↗
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
👨⚕️ Katarzyna Kotulska-Jozwiak, The Children's Memorial Health Institute📍 2 sites📅 Started May 2021View details ↗
Study of the Disease Process of Lymphangioleiomyomatosis
👨⚕️ Joel Moss, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Dec 1995View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →